Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
by from Morbidity and Mortality Weekly Report (MMWR) on (#6Q0DV)
This report describes ACIP recommendations for the use of the RSV vaccine for older adults.